Peter A. Singer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Peter A. Singer has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
D K Martin
2 shared publicationsC Saiphoo
1 shared publication- C. David Naylor
Department of Medicine & Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
1 shared publication D C Mendelssohn
1 shared publicationD Kim
1 shared publicationDavid C. Mendelssohn
1 shared publication
Latest Publications
- 1 June 1999
- Vol. 26 (6) , 1217-8
Bone marrow transplant for rheumatoid arthritis: the costs of a cure.
- 1 June 1999
- Vol. 26 (6) , 1217-8
Bone marrow transplant for rheumatoid arthritis: the costs of a cure.
- Open Access
- 27 April 1998
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 158 (8) , 879-884
Reconceptualizing Advance Care Planning From the Patient's Perspective
DEATH IS often preceded by the use of life-sustaining treatments, but patients are often incapable of making decisions about treatment at such times. Therefore, people sometimes use advance care planning (ACP) to make these decisions ahead of time. Four traditional academic assumptions about ACP have been advocated in various sources in the medical literature: (1) the purpose of ACP is preparing for incapacity1,2; (2) ACP is based on the ethical principle of autonomy and the exercise of control3-5; (3) the focus of ACP is completing written advance directive (AD) forms6-8; and (4) ACP occurs within the context of the physician-patient relationship.2,7,9-11
- 27 April 1998
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 158 (8) , 879-884
Open AccessReconceptualizing Advance Care Planning From the Patient's Perspective
DEATH IS often preceded by the use of life-sustaining treatments, but patients are often incapable of making decisions about treatment at such times. Therefore, people sometimes use advance care planning (ACP) to make these decisions ahead of time. Four traditional academic assumptions about ACP have been advocated in various sources in the medical literature: (1) the purpose of ACP is preparing for incapacity1,2; (2) ACP is based on the ethical principle of autonomy and the exercise of control3-5; (3) the focus of ACP is completing written advance directive (AD) forms6-8; and (4) ACP occurs within the context of the physician-patient relationship.2,7,9-11
- 1 November 1995
- Vol. 6 (5) , 1410-7
Life-sustaining treatment preferences of hemodialysis patients: implications for advance directives.
The purpose of this study was to describe the life-sustaining treatment preferences of dialysis patients and to compare the acceptability of two generic and a disease-specific advance directive (AD). Of 532 potentially eligible hemodialysis patients, 95 (17.9%) participated in the study. These patients completed two generic (the Centre for Bioethics Living Will and the Medical Directive) and one disease-specific (the Dialysis Living Will) AD in a randomized cross-over trial. Treatment preferences were measured by using the Centre for Bioethics Living Will. Acceptability of the AD was measured by using a 13-item advance directive acceptability questionnaire (ADAQ) for each AD, and the advance directive choice questionnaire (ADCQ) to elicit participants' preferred AD. Twenty-five percent of the participants wanted to continue dialysis in case of severe stroke, 19% in severe dementia, and 14% in permanent coma. Averaged across treatments, proportions of participants wanting treatment in various health states were: current health (86%), mild stroke (84%), moderate stroke (60%), severe stroke (21%), mild dementia (78%), moderate dementia (51%), severe dementia (14%), terminal illness (41%), and permanent coma (10%). Averaged across health states, proportions of participants wanting various types of treatment were: dialysis (58%), antibiotics (53%), transfusion (53%), surgery (48%), cardiopulmonary resuscitation (48%), respirator (47%), and tube feeding (41%). Mean ADAQ scores were: Dialysis Living Will, 71%; Centre for Bioethics Living Will, 70%; and Medical Directive, 60% (F = 8.27, P < 0.001 (repeat measures analysis of variance); the Dialysis Living Will and Centre for Bioethics Living Will scored significantly higher than the Medical Directive). The proportion of participants who said they would choose to complete each AD was: Dialysis Living Will, 28%; Centre for Bioethics Living Will, 38%; Medical Directive, 31%; and unsure, 3% (chi 2 = 1.465, df = 2, P = 0.48). In conclusion, twenty-five percent or less of hemodialysis patients want to continue dialysis in three specific health states: severe stroke, severe dementia, and permanent coma. Health states and illness severity, far more than treatment descriptions, influence preferences. Dialysis patients should be offered a generic AD, and some generic AD are more acceptable than others. Only a minority of dialysis patients will complete any AD, but the completion of written AD forms is only one element in the process of advance care planning.
- 1 November 1995
- Vol. 6 (5) , 1410-7
Life-sustaining treatment preferences of hemodialysis patients: implications for advance directives.
The purpose of this study was to describe the life-sustaining treatment preferences of dialysis patients and to compare the acceptability of two generic and a disease-specific advance directive (AD). Of 532 potentially eligible hemodialysis patients, 95 (17.9%) participated in the study. These patients completed two generic (the Centre for Bioethics Living Will and the Medical Directive) and one disease-specific (the Dialysis Living Will) AD in a randomized cross-over trial. Treatment preferences were measured by using the Centre for Bioethics Living Will. Acceptability of the AD was measured by using a 13-item advance directive acceptability questionnaire (ADAQ) for each AD, and the advance directive choice questionnaire (ADCQ) to elicit participants' preferred AD. Twenty-five percent of the participants wanted to continue dialysis in case of severe stroke, 19% in severe dementia, and 14% in permanent coma. Averaged across treatments, proportions of participants wanting treatment in various health states were: current health (86%), mild stroke (84%), moderate stroke (60%), severe stroke (21%), mild dementia (78%), moderate dementia (51%), severe dementia (14%), terminal illness (41%), and permanent coma (10%). Averaged across health states, proportions of participants wanting various types of treatment were: dialysis (58%), antibiotics (53%), transfusion (53%), surgery (48%), cardiopulmonary resuscitation (48%), respirator (47%), and tube feeding (41%). Mean ADAQ scores were: Dialysis Living Will, 71%; Centre for Bioethics Living Will, 70%; and Medical Directive, 60% (F = 8.27, P < 0.001 (repeat measures analysis of variance); the Dialysis Living Will and Centre for Bioethics Living Will scored significantly higher than the Medical Directive). The proportion of participants who said they would choose to complete each AD was: Dialysis Living Will, 28%; Centre for Bioethics Living Will, 38%; Medical Directive, 31%; and unsure, 3% (chi 2 = 1.465, df = 2, P = 0.48). In conclusion, twenty-five percent or less of hemodialysis patients want to continue dialysis in three specific health states: severe stroke, severe dementia, and permanent coma. Health states and illness severity, far more than treatment descriptions, influence preferences. Dialysis patients should be offered a generic AD, and some generic AD are more acceptable than others. Only a minority of dialysis patients will complete any AD, but the completion of written AD forms is only one element in the process of advance care planning.
- 1 January 1994
- Vol. 12, 215-29
Ethical considerations in liver transplantation.